Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-05-30Clinical Trial Update: A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients [Phase 3]
A prospective randomized trial comparing Laparoscopic Nissen fundoplication against anterior partial fundoplication for gastroesophageal ref…
-
CLINICAL_TRIALS trial_result · 2007-05-11Clinical Trial Update: Esomeprazole and Gastric Emptying of Beer [Phase 4]
Phase 4 trial from Heidelberg University evaluating the effect of esomeprazole on gastric emptying of beer in people with gastroesophageal r…
-
CLINICAL_TRIALS research · 2007-04-30Clinical Trial Update: Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux
A ClinicalTrials.gov study characterizes the functional and molecular features of the distal esophageal epithelium and examines its correlat…
-
FDA approval · 2007-04-27FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca, resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: Sleep Disorders and Gastroesophageal Reflux Disease (GERD) [Phase 4]
Phase 4 clinical trial update from University of North Carolina investigating insomnia and gastroesophageal reflux disease; the study status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-03-21FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole by Sandoz Inc. This action updates the current approval for this generic drug.
-
FDA approval · 2007-03-16FDA Approved: CIMETIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for cimetidine, approving changes to its labeling/indication. This update broadens or clarifies…
-
FDA label_change · 2007-01-24FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for metoclopramide from Teva Pharmaceuticals USA, Inc., resulting in changes to the product labe…
-
CLINICAL_TRIALS trial_result · 2006-12-25Clinical Trial Update: Clinical Outcome of Laparoscopic Versus Open Nissen Fundoplication in Children: 3-Year Follow-up Study of Randomized Controlled Trial.
This document reports 3-year outcomes from a randomized trial comparing laparoscopic versus open Nissen fundoplication in children.
-
FDA approval · 2006-10-20FDA Approved: NEXIUM — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved Nexium (esomeprazole magnesium) as AstraZeneca's original NDA. The approval established Nexium as a proton pump inhibitor for a…
-
FDA approval · 2006-10-13FDA Approved: RANITIDINE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's original application for generic ranitidine, authorizing its commercial ranitidine…
-
CLINICAL_TRIALS trial_result · 2006-10-12Clinical Trial Update: Laparoscopy in Children: Does it Decrease the Metabolic, Endocrine and Inflammatory Stress Response to Surgery [NA]
A completed clinical trial in children assessing whether laparoscopy reduces metabolic, endocrine, and inflammatory stress responses to surg…
-
FDA approval · 2006-09-26FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., enabling the marketing of the generic omeprazole product.
-
FDA approval · 2006-09-25FDA Approved: FAMOTIDINE — Original Application (Chain Drug Consortium, LLC)
The FDA approved Chain Drug Consortium, LLC's original application for famotidine, enabling a generic version of famotidine to be marketed. …
-
FDA approval · 2006-09-25FDA Approved: ACID RELIEF — Original Application (Rite Aid Corporation)
The FDA approved ACID RELIEF (famotidine) from Rite Aid under an Original Application (ANDA), making a generic famotidine product available.
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice [Phase 4]
Phase 4 clinical trial update examining long-term use of proton-pump inhibitors in general practice, with conditions including dyspepsia, ga…
-
FDA approval · 2006-07-25FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) submitted by Wyeth Pharmaceuticals LLC, a sub…
-
FDA approval · 2006-06-09FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC, supporting a higher-strength formu…